China Resources Pharmaceutical Group (HKSE:03320) Purchase Of Business : HK$-524 Mil (TTM As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group Purchase Of Business?

China Resources Pharmaceutical Group's purchase of business for the six months ended in Jun. 2024 was HK$-447 Mil. It means China Resources Pharmaceutical Group spent HK$447 Mil on purchasing business. China Resources Pharmaceutical Group's purchase of business for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-524 Mil.

Compared with last quarter (HK$-77 Mil in Dec. 2023 ), China Resources Pharmaceutical Group spent more money on purchasing business in Jun. 2024 (HK$-447 Mil).

China Resources Pharmaceutical Group Purchase Of Business Historical Data

The historical data trend for China Resources Pharmaceutical Group's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Pharmaceutical Group Purchase Of Business Chart

China Resources Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Business

Get a 7-Day Free Trial

-1,696.24

-1,532.73

-2,833.14

-1,142.72

-90.40

China Resources Pharmaceutical Group Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Purchase Of Business	Get a 7-Day Free Trial															-53.41	-1,091.84	-13.55	-76.85	-446.87

China Resources Pharmaceutical Group Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-524 Mil.

China Resources Pharmaceutical Group Purchase Of Business Related Terms

Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Pharmaceutical Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (HKSE:03320) » Definitions » Purchase Of Business

Traded in Other Exchanges

640:Germany

Address

26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, HKG

Website

https://www.crpharm.com

China Resources Pharmaceutical is the third-largest medical distributor in China by revenue. It is an integrated pharmaceutical company specializing in research and development, manufacturing, medical distribution, and retail pharmacies. As of 2023, the medical distribution business accounts for 82.6% of its total revenue. CR Pharma's manufacturing business, 17.8% of total revenue, has subsidiaries with a strong presence in traditional Chinese medicine and consumer healthcare.

Executives

Bei Jing Guo You Zi Ben Yun Ying Guan Li You Xian Gong Si

2201 Interest of corporation controlled by you

China Resources Pharmaceutical Group Headlines

No Headlines